EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
60.00
-1.50 (-2.44%)
At close: Mar 5, 2026
2.56% (1Y)
| Market Cap | 107.09M |
| Revenue (ttm) | 9.37M |
| Net Income (ttm) | 2.38M |
| Shares Out | 1.78M |
| EPS (ttm) | 1.34 |
| PE Ratio | 44.94 |
| Forward PE | n/a |
| Dividend | 1.83 (3.05%) |
| Ex-Dividend Date | n/a |
| Volume | 254 |
| Average Volume | 68 |
| Open | 61.50 |
| Previous Close | 61.50 |
| Day's Range | 60.00 - 61.50 |
| 52-Week Range | 56.00 - 65.50 |
| Beta | -0.07 |
| RSI | 44.92 |
| Earnings Date | Feb 10, 2026 |